Apellis Pharmaceuticals, Inc. (APLS) vs BridgeBio Pharma, Inc. (BBIO)
Detailed comparison between Apellis Pharmaceuticals, Inc., BridgeBio Pharma, Inc..Total Return (%)
Apellis Pharmaceuticals, Inc. (APLS)BridgeBio Pharma, Inc. (BBIO)
- Apellis Pharmaceuticals, Inc.
- BridgeBio Pharma, Inc.
Which stock do you think will perform better?
Apellis Pharmaceuticals, Inc.
APLS
BridgeBio Pharma, Inc.
BBIO
Metric | Apellis Pharmaceuticals, Inc. (APLS) | BridgeBio Pharma, Inc. (BBIO) |
---|---|---|
Current Price | $17.52 | $35.68 |
Change | 0.22 (1.27%) | 1.51 (4.42%) |
Market Cap | $2.20B | $6.77B |
Trailing P/E | 0.00 | 0.00 |
Forward P/E | -20.86 | -11.66 |
Dividend Yield | 0.00% | 0.00% |
52-Week High | $43.99 | $39.54 |
52-Week Low | $16.65 | $21.62 |
Beta | 0.00 | 0.00 |
Earnings Per Share | $-1.60 | $-3.56 |
Processing data. Please try again later.
Average Return
- Apellis Pharmaceuticals, Inc.
- BridgeBio Pharma, Inc.
Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
---|---|---|---|---|---|---|
APLS | -9.36% | -36.73% | -57.48% | -42.25% | 24.88% | 24.88% |
BBIO | 2.38% | 0.21% | 23.25% | 16.60% | 29.51% | 29.51% |